Labor Market Pulse · Life Sciences · September 2026
Life Sciences Labor Market Report: Burlington, NC MSA — September 2026
Triangle expansion is quietly draining Burlington's life sci talent edge.
Alamance County's $1,055 average weekly wage trails the state's $1,198 even as nearby Amgen and J&J projects worth $3B combined pull specialized biomanufacturing talent toward Wilson County and Holly Springs.
Free archive edition. Published by WageScape as sent to subscribers; data as of September 2026.
Key indicators
- Alamance County unemployment: 3.6% — vs 3.5% NC, 4.1% national (Aug 2026)
- Alamance avg weekly wage: $1,055 — vs $1,198 NC statewide average
- Regional biomanufacturing investment: $3B combined — Amgen Holly Springs + J&J Wilson County
- CRA advertised pay, metro: $90,955 — up significantly, tracks national $90,956
Key takeaways
Burlington wages are falling behind a Triangle talent magnet.
Alamance County's $1,055 average weekly wage sits roughly 12% below the state figure of $1,198, even as nearby Amgen and J&J projects advertise premium biomanufacturing pay. Expect sharpening retention pressure on quality, CMC, and manufacturing talent with mobility toward Wilson County and Holly Springs.
Tight local unemployment masks a thin specialized bench.
A 3.6% county unemployment rate signals general labor scarcity, but statewide forums this month openly questioned whether North Carolina's biomanufacturing workforce pipeline can keep pace with expansion. Entry-level operator pipelines like Wilson County's BioWork program are scaling, but they do not address the regulatory and scientific talent gap Burlington employers face.
CRA pay surge signals where clinical hiring pressure concentrates.
Clinical Research Associate advertised pay rose to a metro median of $90,955, tracking the national figure almost exactly and reflecting broad national pressure on clinical execution roles even amid selective biopharma layoffs. Consider benchmarking CRA offers against current postings rather than prior-year survey data, given how quickly this figure has moved.
Lab tech pay decline may reflect softening entry-level demand, not supply relief.
Metro lab technician advertised pay dropped to $49,383, a significant decline that outpaces the national drop to $47,402. This may suggest entry-level hiring has slowed locally even as scarcity persists for credentialed scientific and regulatory roles — a bifurcation worth confirming before assuming broad-based easing.
Median advertised pay by role — Burlington, NC MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist * | $103,601 | $123,500 | $136,449 | Moderate increase | $131,354 |
| Clinical Research Associate * | $61,514 | $90,955 | $108,600 | Significant increase | $90,956 |
| Lab Technician * | $41,439 | $49,383 | $56,836 | Significant decline | $47,402 |
| Regulatory Affairs Specialist * | $77,989 | $119,275 | $119,887 | Significant increase | $104,000 |
| Clinical Data Manager * | $101,184 | $118,202 | $121,795 | Stable | $123,031 |
| Biostatistician * | $113,295 | $142,332 | $169,605 | Significant increase | $133,322 |
| Validation Engineer * | $90,115 | $96,700 | $108,040 | Stable | $108,377 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Burlington's labor market stayed historically tight through midsummer, with Alamance County unemployment at 3.6% and the metro at 3.8% in July 2026, even as the county's average weekly wage of $1,055 trails both state ($1,198) and national benchmarks. Statewide biomanufacturing expansion — anchored by Amgen's $1B Holly Springs project and J&J's $2B Wilson County campus — is pulling specialized talent toward the Triangle corridor, intensifying competition for the scientific and quality talent Burlington employers like LabCorp need to retain.
What it means
Low unemployment combined with below-average local wages creates a structural retention risk: Burlington-based employers compete on pay against Triangle-area biomanufacturing projects offering premium compensation and new-build excitement, while local wage growth has gone flat to negative year-over-year. Specialized regulatory, quality, and CMC talent increasingly has leverage to negotiate location-agnostic offers or relocate toward Wilson and Holly Springs investment corridors, raising the real cost of counteroffers and backfills. Organizations should evaluate whether current pay positioning for mid-to-senior scientific and quality roles reflects Triangle-adjacent competition rather than legacy Alamance County wage norms.
Looking ahead
Worth watching: NC Life Sciences Organization's September 23 forum on biomanufacturing workforce sufficiency may surface employer survey data or policy proposals relevant to regional talent-sharing arrangements. Watch for signals on whether Triangle-area investment projects are actively recruiting from Alamance County employers.
Emerging pressure point: North Carolina's 61 WARN notices in 2026 include 13 healthcare notices affecting 1,455 workers statewide. Monitor whether any Alamance-area clinical or diagnostic employers appear in upcoming filings, which could both release talent locally and signal broader sector consolidation.
Potential inflection point: Wilson Community College's pending $36.4M BioWork hub expansion will scale operator-level graduates feeding J&J, Fresenius Kabi, and Merck. If this pipeline matures faster than expected, Burlington employers may face intensified competition specifically for the next tier of technician-to-specialist promotions.
Early indicator: National CRA pay has moved up significantly alongside a reported 64% of biopharma organizations still actively recruiting despite September layoff announcements. Expect this divergence between consolidation headlines and execution-role hiring to persist, keeping pressure on clinical staffing budgets through year-end.
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.